The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized controlled phase III trial of weekly paclitaxel ± ofranergene obadenovec (VB-111) for platinum-resistant ovarian cancer (OVAL Study/GOG 3018).
 
Rebecca Christian Arend
Employment - Signatera (I)
Consulting or Advisory Role - Caris Life Sciences; GlaxoSmithKline; KIYATEC; Leap Therapeutics; Merck; Seagan; Sutro Biopharma; VBL Therapeutics
Research Funding - Champions Oncology; Exelixis; GlaxoSmithKline; Immunogen; Merck
Travel, Accommodations, Expenses - Caris Life Sciences; GlaxoSmithKline; VBL Therapeutics
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Macrogenics; Merck; Mersana; Myriad Pharmaceuticals; Novartis; Novocure; OncoC4; Pfizer; Pieris Pharmaceuticals; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Consulting or Advisory Role - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Merck; Mersana; Myriad Pharmaceuticals; Novartis; Novocure; OncoC4; Pfizer; Pieris Pharmaceuticals; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Merck; Roche/Genentech; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Ronnie Shapira-Frommer
No Relationships to Disclose
 
Angeles Alvarez Secord
Honoraria - Myriad Genetics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immutep (Inst); Merck (Inst); OncoQuest Pharmaceuticals (Inst); PharmaMar (Inst); Seagen (Inst); Tesaro (Inst); VBL Therapeutics (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Aravive; GOG Foundation; OncoQuest Pharmaceuticals; Regeneron; Roche/Genentech; VBL Therapeutics
 
Thomas J. Herzog
Leadership - GOG Foundation
Consulting or Advisory Role - Aravive; AstraZeneca; Caris MPI; Clovis Oncology; Eisai; Epsilogen; GlaxoSmithKline; Johnson & Johnson; Merck; Mersana; Roche/Genentech; Seagen
 
Krishnansu Sujata Tewari
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Roche/Genentech; Tesaro
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Merck (Inst); Morphotek (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Jonathan A. Ledermann
Consulting or Advisory Role - Amgen; Artios; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck; VBL Therapeutics
Speakers' Bureau - Clovis Oncology; Eisai; Pfizer; Tesaro/GSK
Research Funding - AstraZeneca; MSD Oncology
Other Relationship - Regeneron
 
Tamar Rachmilewitz Minei
Employment - VBL Therapeutics
 
Marc E. Buyse
Employment - IDDI
Stock and Other Ownership Interests - IDDI
 
Ashley Haggerty
No Relationships to Disclose
 
Edwin A Alvarez
Consulting or Advisory Role - Eisai; GlaxoSmithKline; Immunogen; OncoSec
Research Funding - Aravive (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Merck (Inst); Sumitomo Pharma Oncology (Inst); Tesaro/GSK (Inst); VBL Therapeutics (Inst)
 
Amnon Amit
No Relationships to Disclose
 
Carolyn Muller
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - agenus (Inst); AstraZeneca (Inst); Genmab (Inst); Incyte (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Roche/Genentech (Inst); TapImmune Inc. (Inst); VBL Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Have a pending patent on the cancer use for R-ketorolac - not yet its own new drug. (Inst)
Other Relationship - Department of Defense; FDA; NCI; NCI
 
Antonio Casado Herraez
Consulting or Advisory Role - EISAI; EISAI; Merck Sharp & Dohme; PharmaMar; Roche
Research Funding - Pharmamar (Inst)
Travel, Accommodations, Expenses - Lilly; PharmaMar; Pharmamar; Roche
Other Relationship - Lilly (Inst)
 
Laura L. Holman
No Relationships to Disclose
 
Joshua Cohen
No Relationships to Disclose
 
Marilyn Huang
No Relationships to Disclose
 
Adelya Yachnin
No Relationships to Disclose
 
Dror Harats
Employment - Vascular Biogenics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - ART Health Solutions; VBL Therapeutics
Honoraria - Novartis
Consulting or Advisory Role - Medison
Patents, Royalties, Other Intellectual Property - I have few patents at the Medicalcenter at Sheba
 
Richard T. Penson
Honoraria - AstraZeneca; Genentech/Roche; GlaxoSmithKline; Immunogen; Merck; Mersana; Novocure; Sutro Biopharma; Vascular Biogenics
Consulting or Advisory Role - AstraZeneca; Care4ward; Genentech; GlaxoSmithKline; Immunogen; Merck; Mersana; Novocure; Sutro Biopharma; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Other Relationship - AstraZeneca; Roche